当前位置: X-MOL 学术J. Mol. Cell Biol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera
Journal of Molecular Cell Biology ( IF 5.3 ) Pub Date : 2021-08-27 , DOI: 10.1093/jmcb/mjab050
Kei Miyakawa 1 , Sundararaj Stanleyraj Jeremiah 1 , Hideaki Kato 2 , Yutaro Yamaoka 1, 3 , Hirofumi Go 4 , Satoshi Yajima 5 , Tomoko Shimada 6 , Takahiro Mihara 7 , Atsushi Goto 7 , Takeharu Yamanaka 4, 7 , Akihide Ryo 1
Affiliation  

The uncontrolled spread of the coronavirus disease 2019 (COVID-19) pandemic has led to the emergence of different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants across the globe. The ongoing global vaccination strategy to curtail the COVID-19 juggernaut is threatened by the rapidly spreading variants of concern (VOC) and other regional mutants, which are less responsive to neutralization by infection- or vaccine-derived antibodies (Gomez et al., 2021; Wang et al., 2021).

中文翻译:

快速检测疫苗接种后血清中针对 SARS-CoV-2 变体的中和抗体

2019 年冠状病毒病 (COVID-19) 大流行的不受控制的传播导致全球出现了不同的严重急性呼吸系统综合症冠状病毒 2 (SARS-CoV-2) 变体。正在实施的旨在遏制 COVID-19 主宰的全球疫苗接种战略受到快速传播的关注变体 (VOC) 和其他区域突变体的威胁,这些变体对感染或疫苗衍生抗体的中和反应较弱(Gomez 等人,2021 年) ;王等人,2021)。
更新日期:2021-08-27
down
wechat
bug